Clinical utility of glycated albumin and 1,5-anhydroglucitol in the screening and prediction of diabetes: A multi-center study

Table 2 Circulating levels of fasting plasma glucose, glycated hemoglobin, glycated albumin and 1,5-anhydroglucitol of morbidly-obese patients with diabetes at baseline, one and three months after the bariatric surgery

	Baseline (n = 24)	1-month (n = 13)	3-month (n = 14)	P for trend
FPG (mmol/L)	8.27 ± 2.77	5.37 ± 0.83	5.23 ± 0.86	< 0.001
HbA1c (%)	7.18 ± 1.56	6.24 ± 1.14	5.33 ± 0.52	< 0.001
GA (%)	19.00 ± 5.98	10.85 ± 3.16	11.72 ± 2.97	< 0.001
1,5-AG (µmol/L)	61.09 ± 48.17	75.05 ± 53.77	80.28 ± 40.79	< 0.001

Data are presented as mean ± SD. FPG: Fasting plasma glucose; HbA1c: Glycated hemoglobin; GA: Glycated albumin; 1,5-AG: 1,5-anhydroglucitol.